RxDoctor Payments Data

Benjamin Hennessee, PA

Medical · Henderson, NCNPI 1912105164

Payments from drug & device makers

$575in general payments, 2019–2025

Across 34 payments — averaging $16.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$110
  • Lilly USA, LLC$97
  • GSK$86
  • Pfizer$67
  • Braeburn Inc.$43
  • Exact Sciences$36
  • plus $137 from 6 others

What the payments were for

  • Food & beverage$575100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$575 in reported general payments places this provider in the 55th percentile of 878 medical providers in North Carolina.

See all medical providers in North Carolina

Medicare billing

Part B allowed, 2024
$1,330
Medicare patients
36
Services billed
145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter80$84,006
TrulicityDulaglutide68$75,214
OzempicSemaglutide73$73,224
EliquisApixaban72$69,005
FarxigaDapagliflozin Propanediol46$53,829
XareltoRivaroxaban34$44,079
JardianceEmpagliflozin29$34,961
LinzessLinaclotide33$32,544
EntrestoSacubitril/Valsartan21$28,621
Tresiba Flextouch U-200Insulin Degludec26$17,032
Spiriva HandihalerTiotropium Bromide15$14,193
SunosiSolriamfetol Hcl13$11,875
SymbicortBudesonide/Formoterol Fumarate43$11,693
Victoza 3-PakLiraglutide15$11,516
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr23$11,234

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta$86$104,932127 claims
Lilly USA, LLCTrulicity$97$75,21468 claims
Novo NordiskOzempic$110$73,22473 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$17$72,273100 claims
PfizerEliquis$67$69,00572 claims
Johnson & JohnsonXarelto$32$44,07934 claims
MerckJanuvia, Dulera$14$12,22223 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 878 medical providers in North Carolina.

Other medical in Henderson

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →